ChemicalBook >> CAS DataBase List >>Reverse transcriptase-IN-1

Reverse transcriptase-IN-1

CAS No.
2380001-43-2
Chemical Name:
Reverse transcriptase-IN-1
Synonyms
Reverse transcriptase-IN-1;Benzonitrile, 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2-methyl-6-nitrophenyl]amino]-2-quinazolinyl]amino]-;Human immunodeficiency virus,Reverse transcriptaseIN1,Inhibitor,Reverse transcriptase IN 1,inhibit,HIV
CBNumber:
CB68054520
Molecular Formula:
C25H17N7O2
Molecular Weight:
447.45
MDL Number:
MFCD32263435
MOL File:
2380001-43-2.mol
Last updated:2023-05-21 10:59:17

Reverse transcriptase-IN-1 Properties

Boiling point 708.3±70.0 °C(Predicted)
Density 1.42±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
pka 7.22±0.30(Predicted)

Reverse transcriptase-IN-1 Chemical Properties,Uses,Production

Biological Activity

Reverse transcriptase-IN-1 (Compound 12z), a diarylbenzopyrimidine (DABP) analogue, is a potent, orally active HIV-1 nonnucleoside reverse transcriptase inhibitor. Reverse transcriptase-IN-1 has antiviral activity with EC50 values of 3.4 nM, 4.3 nM and 3.6 nM for HIV-1 IIIB, E138K and K103N mutants, respectively. Reverse transcriptase-IN-1 also has an IC50of 13.7 nM against HIV-1 reverse transcriptase enzyme[1]. The oral bioavailability of Reverse transcriptase-IN-1 (Compound 12z) is significantly improved to 16.5% at a dose of 5 mg/kg in rats. The intrinsic rat microsome clearance of Reverse transcriptase-IN-1 is 33.2 μL/min/mg proteins. The PK study and safety assessment of Reverse transcriptase-IN-1 shows that it is absorbed with mean residence times (MRTs) of 11.8 hours (5 mg/kg, p.o.) and 11.4 hours (1 mg/kg, i.v.) at these two doses. The Cmax of Reverse transcriptase-IN-1 is 39.9 ng/mL at a dose of 5 mg/kg. A single-dose toxicity test of Reverse transcriptase-IN-1 in rats shows no mortality, and there is no abnormal body weight decrease in the animals in the week following an intragastrical dose at 293 mg/kg body weigh. The above results indicate that Reverse transcriptase-IN-1 could be an orally bioavailable candidate for human HIV-1 infection research[1].

References

[1]. Han S, et al. Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles. ACS Infect Dis. 2019 Oct 24.

Reverse transcriptase-IN-1 Preparation Products And Raw materials

Raw materials

Preparation Products

Reverse transcriptase-IN-1 Suppliers

Global( 8)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Shanghai SuperLan Chemcial Technique Centre 021-2022843681 15618226720 chaolaichem@foxmail.com China 7565 58
cjbscvictory 13348960310 13348960310 3003867561@qq.com China 9946 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24131 58
Yantai Lianhua Technology Co., Ltd 15552437730 1701654643@qq.com China 11397 58
RD International Technology Co., Limited 18988968278 sales@ubiochem.com China 9146 58
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 15850508050 cindy.huang@synzest.com China 12007 58
Reverse transcriptase-IN-1 Human immunodeficiency virus,Reverse transcriptaseIN1,Inhibitor,Reverse transcriptase IN 1,inhibit,HIV Benzonitrile, 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2-methyl-6-nitrophenyl]amino]-2-quinazolinyl]amino]- 2380001-43-2